Related Experiment Video
Updated: Apr 26, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
27.9K
Mapping of ApoE4 Related White Matter Damage using Diffusion MRI
Sinchai Tsao1, Niharika Gajawelli2, Darryl Hwa Hwang3
1University of Washington, Seattle, Washington, USA.
Summary
The apolipoprotein E ε4 (ApoE-ε4) gene variant is linked to Alzheimer's Disease. This study found white matter changes in the hippocampus and posterior cingulum associated with ApoE-ε4, independent of age and cognitive status.
Area of Science:
- Neuroimaging
- Genetics
- Alzheimer's Disease Research
Background:
- Apolipoprotein E ε4 (ApoE-ε4) is a significant genetic risk factor for Alzheimer's Disease (AD).
- The precise mechanisms linking ApoE-ε4 to increased AD risk, potentially involving amyloid-beta (Aβ) clearance and oligomerization, remain unclear.
- Understanding white matter alterations associated with ApoE-ε4 may elucidate its role in cognitive decline.
Purpose of the Study:
- To investigate white matter integrity changes associated with the ApoE-ε4 genotype.
- To identify brain regions affected by ApoE-ε4 independently of aging and clinical dementia severity.
Main Methods:
- Diffusion MRI was used to measure white matter integrity.
- Voxel-based statistical analysis correlated diffusion metrics with ApoE-ε4 genotype.
- Analyses controlled for vascular risk factors, gender, cognitive status (Clinical Dementia Rating - CDR), and age.
Main Results:
- Significant white matter changes (P < 0.05) were identified near the hippocampus and posterior cingulum in individuals with the ApoE-ε4 allele.
- These findings were independent of age-related white matter changes and CDR scores.
- The results suggest ApoE-ε4 influences cognitive decline through pathways distinct from normal aging and acute insults.
Conclusions:
- The ApoE-ε4 genotype is associated with specific white matter alterations in brain regions critical for cognition.
- These structural changes may represent an early mechanism by which ApoE-ε4 confers risk for Alzheimer's Disease.
- Further research into these ApoE-ε4-associated white matter pathways could reveal novel therapeutic targets.

